Lisa Santry
About Lisa Santry
Lisa Santry is a Senior Scientist specializing in Molecular and Viral Vector Biology at ElevateBio, where she conducts advanced research and analytics for AAV therapeutics. With a PhD in Pathobiology from the University of Guelph and extensive experience in purification techniques, she has contributed significantly to the field since 2021.
Work at ElevateBio
Lisa Santry has been employed at ElevateBio since 2021, currently holding the position of Senior Scientist in Molecular/Viral Vector Biology. In this role, she conducts research-grade purification utilizing techniques such as ultra centrifugation, size/steric exclusion, and affinity purification. Her work involves performing analytics for adeno-associated viruses (AAV), including genome titers, capsid titers/ratios, and empty/full capsid analysis. Prior to her current role, she served as Scientist II in the same department from 2020 to 2021.
Education and Expertise
Lisa Santry holds a Bachelor of Science (BSc) in Cell Biology and Anatomy from McGill University. She further advanced her education at the University of Guelph, where she earned a Doctor of Philosophy (PhD) in Pathobiology. Her academic background is complemented by her experience as a PhD candidate at the University of Guelph from 2011 to 2017. Santry specializes in optimizing small-scale proof of concept production for AAV therapeutics.
Background
Lisa Santry completed her high school education at Colonel By Secondary School, where she achieved the International Baccalaureate Diploma. Following her secondary education, she pursued higher education at McGill University and the University of Guelph, focusing on biological sciences. Her career in research has included significant roles in molecular and viral vector biology.
Research Contributions
In her research role, Lisa Santry has led the redesign of triple transfection constructs to develop new serotypes for AAV therapeutics. She conducts proof of concept transduction experiments that focus on expression and integration, contributing to advancements in the field of gene therapy. Her work involves detailed analytics and purification techniques that are critical for the development of AAV-based therapies.